Replimune Group Inc. (REPL)
NASDAQ: REPLHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 13.20 0.00%
REPL stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.24B
- EPS (TTM)
- -$3.15
- Dividend yield
- None
- 52-week range
- 1.50 – 16.33
- Day range
- 13.02 – 13.60
- Volume / Avg
- 1.65M / 4.20M
- Beta
- —
- Shares outstanding
- 94.22M
- Next earnings
- Nov 5, 2026
52-week range
REPL stock today
Shares of Replimune Group (REPL) finished lower on Oct 7 at $13.20, a drop of 0.38% or $0.05 per share, versus the S&P 500's 0.22% decline. Trading was light, with 1.65M shares changing hands, about 39% of the average daily volume. Shares are 19.2% below their 52-week high of $16.33, set on Sep 2, 2026 and 780.0% above the 52-week low of $1.50, in the middle of the past year's range.
REPL is up 35.8% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 183.9%. Replimune Group has posted a net loss over the last twelve months (EPS of -$3.15), so its P/E ratio is not meaningful. Replimune Group's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Replimune Group
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year
- 2018
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $-0.70
Replimune Group peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| COAGHemab Therapeutics Holdings Inc. | 28.70 | +1.16% | $1.34B | vs REPL |
| IMTXImmatics N.V. | 7.45 | -0.67% | $1.13B | vs REPL |
| INBXInhibrx Biosciences Inc. | 93.36 | -0.05% | $1.37B | vs REPL |
| VORVor Biopharma Inc. | 18.78 | +2.57% | $1.11B | vs REPL |
| TSHATaysha Gene Therapies Inc. | 4.43 | +0.91% | $1.44B | vs REPL |
| MGTXMeiraGTx Holdings plc | 10.82 | +2.08% | $1.04B | vs REPL |
| MAZEMaze Therapeutics Inc. | 26.25 | -0.68% | $1.46B | vs REPL |
| IMCRImmunocore Holdings plc ADR | 29.41 | -0.47% | $1.51B | vs REPL |
Indexes, lists and sector
Largest Health Care stocks
Replimune Group stock FAQ
What is Replimune Group's stock price today?
REPL last traded at $13.20 as of Oct 7, 4:00 PM EDT, down 0.38% on the day. Prices are delayed at least 15 minutes.
When is Replimune Group's next earnings date?
Replimune Group is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $-0.70.
What is the REPL 52-week high?
The 52-week high for REPL is $16.33 and the 52-week low is $1.50. The stock is currently 19.2% below its high.